Jason Lettmann is Director & 10% Owner at ALX ONCOLOGY HOLDINGS INC (ALXO). They have made 10 open-market trades across 2 companies since 2016, most recently 2026-08-17.
CIK 0001688269
4 open-market purchases totalling $12.9M since 2016, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RARX | 4,066,503 | $195.2M |
| ALXO | 294,379 | $315K |
| Total | $195.5M |
Shares reported on the most recent Form 4, priced at the 2026-08-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXO | SELL | 2026-08-17 | 2026-08-18 | $1.93 | $4K | -4.8% | -17.1% | — |
| ALXO | SELL | 2026-03-19 | 2026-03-23 | $2.17 | $27K | -9.2% | -21.7% | -24.0% |
| ALXO | BUY | 2025-09-16 | 2025-09-18 | $1.08 | $176K | +48.8% | +34.1% | +17.9% |
| ALXO | SELL | 2025-08-15 | 2025-08-19 | $0.64 | $2K | +30.0% | +21.1% | +73.3% |
| ALXO | SELL | 2025-02-19 | 2025-02-21 | $1.15 | $2K | -5.5% | -37.2% | -56.5% |
| ALXO | BUY | 2024-03-14 | 2024-03-18 | $11.31 | $50K | -0.4% | +43.6% | -34.1% |
| ALXO | SELL | 2021-12-08 | 2021-12-10 | $32.27 | $9.3M | -26.4% | -34.8% | -38.3% |
| ALXO | BUY | 2020-07-21 | 2020-07-21 | $19.00 | $7.6M | +5.8% | +41.6% | +34.5% |
| RARX | BUY | 2016-10-31 | 2016-10-31 | $13.00 | $5.1M | -1.4% | -3.2% | +16.6% |
| RARX | SELL | 2016-10-31 | 2016-10-31 | $13.00 | $5.1M | -1.4% | -3.2% | +16.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.